Evaluation of antidiabetic and antihyperlipedemic potential of aqueous extract of moringa oleifera in fructose fed insulin resistant and STZ induced diabetic wistar rats: A comparative study

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue 1, 2012, Pages 67-72

  Divi, Sai Mangala ^a   Bellamkonda, Ramesh ^b   Dasireddy, Sarala Kumari ^c  

^a SRI SATHYA SAI INSTITUTE OF HIGHER MEDICAL SCIENCES   (India)

^b SRI VENKATESWARA UNIVERSITY   (India)

^c SRI KRISHNADEVARAYA UNIVERSITY   (India)

Author keywords

Glucose intolerance; Insulin resistance; Lipids profile; Moringa oleifera; Streptozotocin

Indexed keywords

FRUCTOSE; GLUCOSE; INSULIN; MORINGA OLEIFERA EXTRACT;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIHYPERLIPEDEMIC EFFECT; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE TOLERANCE; HOMEOSTASIS MODEL OF ASSESSMENT; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPID ANALYSIS; MALE; MORINGA OLEIFERA; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; STREPTOZOCIN DIABETES;

EID: 84856797288     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. WHO, WHO Expert Committee on Diabetes Mellitus. Second Report Geneva. World Health Org 2000.
2. Valiathan MS. Healing plants. Current science 1998; 75: 112-26.
3. Nadkarni AK. Indian Materia Medica. Vol 1 Popular Prakashan: Bombay, 810-816.
4. Mughal MH, Ali G, Srivastava PS, Iqbal M. Improvement of drumstic (Moringa Pterygosperma Gaertn)-a unique source of food and medicine through tissue culture. Hamdard Med 1999; 42:37-42.
5. Anwar F, Bhanger MI. Analytical characterization of Moringra oleifera seed oils grown in temperate regions of Pakistan. J Agric Food Chem 2003; 51: 6558-6563.
6. Faizi S, siddiqui BS, Saleem R, Saddiqui S, Aftab K. Isolation and structure elucidation of new nitrile and mustard oil glycosides from Moringa oleifera and their effect on blood pressure. J Nat Prod 1994 (a): 57: 1256-1261.
7. Faizi S, siddiqui BS, Saleem R, Siddiqui S, Aftab K, Gilani AH. Fully acetylated carbamate and hypotensive thiocarbamate glycosides from Moringa oleifera. Phytochemistry 1995; 38:957-963.
8. Pari L, Karamac M, Kosinska A, Rybarezyk A amarowicz R. Antioxidant activity of the crude extract of drumstick tree (Moringa oleifera) and sweet Broomweed (Scoparia dulcis) leaves. Polish Journal of Food and Nutrition Sciences 2007; 57:203-208.
9. Guevara AP, Vargas C, Sakurai H, et al. An antitumor promoter from Moringa oeifera Lam. Mutat Res 1999; 440: 181-188.
10. Murakami A, Kitazona Y, Jiwajinda S, Koshimizu K, Ohigashi H. Niaziminin a thiocarbamate from the leaves of Moringa oleifera, holds a srict structural requirement for inhibition of tumor-induced Epstein-Barr virus activation. Planta Med 1998; 64: 319-323.
11. Ghasi S, Nwobodo E, Ofili JO. Hypocholesterolemic effects of crude extract of leaf of Moringa oleifera Lam in high-fat diet fed Wistar rats. J. Ethnopharmacol 2000; 69:21-25.
12. Fakurazi S, Nanthini U, Hairuszah I. Hepatoprotective and Antioxidant action of Moringa oliefera Lam, against Acetaminophen induced hepatotoxicity in rats. International Journal of Pharmacology 2008; 4 Suppl 4: 270-275.
13. Lilibeth AC, and Glorina LP. Effects of Moringa oleifera Lam on the reproduction of male mice. Journal of Medicinal Plants Research 2010; 4 (120): 1115-1121.
14. Ndong M, Uhera M, Katsumata S, Suzuku K. Effects of oral administration of Moringa oleifera Lam on Glucose Tolerance in Goto-Kakizaki and Wistar rats. J Clin Biochem Nutr 2007; 40 (3):229-233.
15. Jaiswal D, Kumar Rai P, Kumar A, Mehta S, Watal G. Effect of Moringa oleifera Lam leaves aqueous extract therapy on hyperglycemic rats. J. Ethnopharmacology 2009; 123(3): 392-396.
16. Caceres A, Cabrera O, Morales O, Mollinedo P, Mendia P. Pharmacological properties of Moringa oleifera. Preliminary screening for antimicrobial activity. J Ethnopharmacol 1991; 33:213-216.
17. Brain KR and Turner TD. The practical evaluation of Phyto pharmaceuticals. Wright Scientechnica. Bristol, Britain 1975; p 56-64.
18. Sofowora A. Medicinal plants and traditional medicines in Africa. POPLINE Document no: 018476. John Wiley and sons Ltd (1982). New York.
19. Trease GE and Evans WC (1983). Pharmacognosy 12 th Ed. Bailer Tindall, London
20. Harborne JB. Phytochemical methods: A guide to modern techniques of plant analysis. Chapman and Hall. London 1976; 99-100,109-110, 144-147, 185-188.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
22. Guido S, Joseph J. Effect of chemically different calcium antagonists on lipid profile in rats fed on a high fat diet. Indian Journal of Experimental Biology 1992; 30: 292-294.
23. Pickavance LC, Tadayyon M, Widdowson PS, Buckingham RE, Wilding JP. Therapeutic index for rosiglitazone in dietary obese rats. Separation of efficacy and haemodiluation. Br J Pharmacol 1999; 128: 1570-76.
24. Duncan DB. Multiple range and multiple tests, Biometrics 1955; 42:1-42.
25. Kasim Karakas SE, Vriend H, Almario R, Chow LC, Goodman MN. Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. J Lab Ciln Med 1996; 128:208-213.
26. Reddy SS, Karuna R, Saralakumari D. Prevention of insulin resistance by ingesting aqueous extract of Ocimum sanctum to fructose fed rats. Horm Metab Res 2008; 40: 44-49
27. Kok N, Robertroid M, Deizenne N. Dietary oligo fructose modifies the impact of fructose on hepatic triacylglycerol metabolism. Metabolism 1996; 45: 1547-50.
28. Elliott SS, Keim NL, Stem JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002; 76: 911-22.
29. Shulman GL. Cellular machanisms of insulin resistance in humans. Am J Cardiol 1999; 84 (suppl 1A): 3J-10J.
30. Kim JK, Gavrilova O, chen Y, Shulman GI. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice, J Biol Chem 2000; 275:8456-8460.
31. Bezerra RMN, Ueno M, Silva MS, Tavares DQ, Carvalho CRO, Saad MJA.A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr 2000; 130: 1531-35.
32. Chatterje MN, Shinde R. Text book of medical biochemistry 4 nd edition. Jaypee Brothers medical publishers, New Delhi, 2000.
33. Cano DA, Rulifson IC, Heiser PW, Swigart LB, Pelengaris S, German M, Evan GI, Bluestone JA, Hebrok M. Regulated β-cell regeneration in the adult mouse pancreas. Diabetes 2008; 57: 958-66.
34. Yadav H, Jain S, Prasad GBKS, Yadav M. Preventive effect of Diabecon, a polyherbal preparation during progression of diabetes induced by high fructose feeding in rats. J Pharmacol Sci 2007; 105: 12-21.
35. Hsu JH, Wu YC, Liu IM, Cheng JT. Diascorea as the principal herb of Die-Huang-Wan, a widely used herbal mixture in China for improvement of insulin resistance in fructose rich chow-fed rats. J Ethnopharmacol 2007; 112(3): 577-84.
36. Ramesh B, Karuna R, Reddy SS, Ramesh K, Ramatholisamma P, Appa Rao CH, Saralakumari D. Antihyperglycemic and antioxidant activities of alcoholic extract of Commiphora mukul gum resin in Streptozotocin induced diabetic rats. Pathophysiology 2011; 18:255-261.
37. Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y. Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J Nutr 2002; 132: 3379-82.
38. Kazumi T, Odaka H, Hozumi T, Ishida Y, Amano N, Yoshino G. Effects of dietary fructose or glucose on triglyceride production and lipogenic enzyme activities in the liver of Wistar fatty rats, an animal model of NIDDM. Endocr J 1997; 44: 239-45.
39. Remillard P, Shen G, Milne R, Maheux P. Induction of cholesterol ester transfer protein in adipose tissue and plasma of the fructose fed hamster. Life Sci 2001; 69: 677-687.
40. Zavaroni I, Chen YDI, Reaven GM. Studies of the mechanism of fructose-induced hypertriglyceridemia in the rat. Metabolism 1982; 311: 1077-83.
41. Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk 2000; 7: 325-331.
42. Benadoa M, Alcantaraa C, DeLa Rosa R, Ambrosea M, Mosiera K, Kerna M Effects Of various levels of dietary fructose on blood lipids of rats. Nutrition Research 2004; 24(7): 565-571.
43. Limin W, Jhu Y, Rosemary L, Waisem High carbohydrate diets affect the size and composition of plasma lipoproteins in hamsters (Mesocricetus auratus). Comparative Medicine 2008; 58 (2): 151-160.
44. Mooradian Ad, Wong NC, Shah GN. Apolipoprotein AI{cyrillic, ukrainian} expression in young and aged rats is modulated by dietary carbohydrates. Metabolism 1997; 46:1132-1136.
45. Pilaipark C, Panya K, Yupin S, Srichan P, Noppowan PM, Laddawal PN, Piyani R, Supath S, Klai USP. The in vitro and ex vivo antioxidant properties, hypolipidimic and antiatherosclerotic activities of water extract of Moringa oliefera Lam. Leaves. Journal of Ethnopharmacology 2008; 116:439-446.
46. Turner RC, Millins H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR. Risk factors for coronary artery disease in non insulin dependant diabetes mellitus;United Kingdom prospective Diabetes Study(UKPDS:23). Br Med J 1998; 316:823-828.
47. Gowri MS, Van der Westhuyzen DR, Bridges SR, Anderson JW. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. ArteriosclerThromb Vasc Biol 1999; 19:2226-2233
48. Umesh Yadav CS, Moorthy K, Najma ZB. Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alteration in lipid profile and lipogenic enzymes in alloxan diabetic rats. Molecular and cellular Biochemistry 2005; 268:111-120.
49. Numano F, Tanaka A, Makita T, Kishi Y. Glycated lipoprotein and atherosclerosis. Ann NY Acad Sci 1997; 811: 100-114.
50. Retsky KL, Chen K, Zeind J, Frei B. Inhibition of copper induced LDL oxidation by vitamin C is associated with decreased copper binding to LDL and 2-oxo-histidine formation. Free Radic Biol Med 1999; 26: 90-8.
51. Nandave M, Ojha SK, Joshi S, kumara S and Arya DVS. Moringa oleifera leaf extract prevents Isoproterenol-Induced myocardial Damage in Rats: Evidence for an Antioxidant, Antoperoxidative, and Cardiopretective Intervention. Journal of Medicinal Food 2009; 12(1):47-55.
52. Ndong M, Uhera M, Katsumata S, Sato S, Suzuki K. Preventive effects of Moringa oleifera (Lam) on hyperlipidemia and hepatocyte ultrastuctural changes in iron deficient rats. Biosci Biotechnol Biochem 2007; 71(8): 1826-1833.
53. Nambiar V.S, Guin P, Parnami S, Daniel M. Impact of antioxidants from drumstick leaves on the lipid profile of hyperlipidemics. Journal of Herbal Medicine and Toxicology 2010; 4(1) 165-172.
54. Vinson J, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods,fruit. J Agric and food Chem 2001; 49(11): 5315-5321.
55. Ivorra MD, Paya M, Villar A. A review of natural products and plants as Potent antidiabetic drugs. J Ethno pharmacol 1989; 27(3): 243-275.
56. Tiwari AK, Madhusudana RJ. Diabetes mellitus and multiple therapeutic approaches of Phytochemicals: present status and future prospects. Current science 2002; 83:30-38.
57. Chakravarthy BK, Gupta S, Gambir SS, Gode KD. Pancreatic beta cell regeneration. A novel antidiabetic mechanism of Pterocarpus marsupium Roxb. Ind J Pharmacol 1980; 12: 123-27.
58. O Byme DJ, Devaraj S, Grundy SM, Jialal L. Comparison of antioxidant effects of Concord grape juice flavanoids and α-tocopherol on markers of oxidative stress in healthy Adults. American Journal of Clinical Nutrition 2002; 76: 1367-1374.
59. Theriault AG, Wang Q, Van Iderstine SC, Chen B, Franke AA, Adeli K. Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavanoid. Journal of Lipid Research 2000; 41: 1969-1979.